SBIR

‘Dormant’ biotech wakes on Alzheimer’s fast track

By GREGORY ZELLER // A pre-clinical-stage biopharmaceutical company is being fast-tracked toward a potential Alzheimer’s treatment, after taking a decidedly slow road. Stony Brook-based Avanti Biosciences Inc. actually launched in 2009, but was “dormant for a few years,” according to founder Gian Luca Araldi, “kind of an empty shell.” It was only in the last two years, when “I had some ideas I wanted to develop on my own,” that Araldi – a former senior…


An SBU sweep in Bioscience Hub’s latest round

By GREGORY ZELLER // Five research projects targeting advanced medical-imaging applications, computer-based drug discoveries and a range of new pharmaceutical treatments will be backed by the Long Island Bioscience Hub. The Center for Biotechnology at Stony Brook University, on behalf of the LIBH, announced Tuesday the fourth funding round of the Hub’s technology-commercialization initiative. This time around, a total of $400,000 has been earmarked for two “feasibility” and three “proof of concept” awards, each backing biomedical…